Universal Sample Bank

USB blood sampleThe Association for Diagnostics & Laboratory Medicine’s (ADLM) Universal Sample Bank includes two separate but interchangeable and complementary sets. Full sets, individual samples, and custom orders can be arranged. Sample sets can be used in a variety of clinical studies, including clinical assay development, standardization, and reference range studies.

Features of ADLM’s Universal Sample Bank Include

Original Sample Bank

ADLM offers pre-screened and well-characterized sample sets from over 700 healthy individuals. The sample set can be used in a variety of clinical studies, including clinical assay development, standardization, and reference range studies. Features of ADLM’s Universal Sample Bank include:

  • Serum/lithium heparin plasma samples available from 700+ healthy individuals
  • Ethnically and geographically diverse adult population (18+)
  • IRB-approved collection protocol
  • Comprehensive de-identified donor data with health screening information
  • Results of HbA1c, Creatinine, and NT-proBNP screens
  • Collected pre-COVID (SARS-CoV-2 negative samples)

Pandemic-era Sample Bank

ADLM offers well-characterized sample sets from almost 700 individuals vaccinated and/or previously infected with SARS-CoV-2. The sample set can be used in the development of COVID-19-related assays and other clinical studies. Features of ADLM’s COVID Sample Bank include:

  • Serum and plasma (LIH & EDTA) sample sets
  • Ethnically and geographically diverse adult population (18+)
  • IRB-approved collection protocol
  • De-identified donor data with comprehensive health screening information and the option of COVID-19-specific information
  • Results of biotin and hsCRP screens

International shipping is available.

Complete the form below to let us know your needs or contact Caitlin Ondracek at [email protected] for more information.

Special Offer

ADLM offers a discounted price for ADLM members who purchase the sample sets for academic research purposes.

We received over 800 samples from unique healthy donors. The data provided was very valuable for my research and helped us establish new reference intervals for emerging biomarkers of cardiac and kidney disease...

—Joe El-Khoury, PhD, DABCC, FADLM, Director, Clinical Chemistry Laboratory, Yale-New Haven Health

How it's contributing to research

  • The first paper from the ADLM COVID Immunity Study has been published in Frontiers in Public Health. This paper focused on the results of the general health and COVID-specific questionnaires and illustrates differences in side effects between Moderna, Pfizer, and Johnson & Johnson vaccines. Learn more.
  • New research from the ADLM COVID Immunity Study demonstrated that neutralizing antibody responses can serve as predictors of breakthrough infection and that T cell assays may aid in predicting breakthrough disease severity after SARS-CoV-2 vaccination.